Fermenta Biotec.

37
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
267.15
2.6 (0.98%)
BSENSE

Dec 05

BSE+NSE Vol: 6.78 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
469.00
335.00
349.00
398.00
377.00
292.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
1.00
1.00
Net Sales
469.00
335.00
349.00
398.00
375.00
291.00
Expenditure (Ex Depriciation)
Stock Adjustments
-31.00
26.00
22.00
6.00
-28.00
-27.00
Raw Materials Consumed
178.00
104.00
131.00
146.00
163.00
106.00
Power & Fuel Cost
27.00
19.00
18.00
20.00
14.00
12.00
Employee Cost
65.00
58.00
57.00
62.00
58.00
50.00
Operating Expenses
59.00
50.00
44.00
45.00
37.00
27.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
17.00
11.00
13.00
17.00
19.00
23.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
11.00
8.00
10.00
7.00
9.00
8.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
358.00
307.00
331.00
336.00
293.00
225.00
Operating Profit (PBDIT) excl Other Income
110.00
27.00
18.00
62.00
82.00
66.00
Other Income
11.00
11.00
8.00
8.00
8.00
12.00
Operating Profit (PBDIT)
122.00
39.00
26.00
70.00
90.00
78.00
Interest
14.00
17.00
21.00
17.00
19.00
20.00
Profit before Depriciation and Tax
107.00
22.00
5.00
52.00
71.00
58.00
Depreciation
24.00
24.00
28.00
25.00
20.00
14.00
Profit Before Taxation & Exceptional Items
83.00
-2.00
-22.00
26.00
51.00
43.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
83.00
-9.00
-51.00
26.00
51.00
43.00
Provision for Tax
6.00
14.00
1.00
11.00
9.00
-16.00
Profit After Tax
76.00
-24.00
-53.00
15.00
42.00
59.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
252.00
279.00
326.00
318.00
272.00
219.00
Profit Available for appropriations
329.00
256.00
275.00
333.00
318.00
279.00
Appropriations
329.00
256.00
275.00
333.00
318.00
279.00
Equity Dividend (%)
50.00%
25.00%
25.00%
25.00%
50.00%
100.00%
Earnings Per Share
26.35
-7.99
-17.70
5.35
15.77
20.63
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 39.87% vs -4.08% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 296.21% vs 53.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -14.53% vs -18.47% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 418.23% vs 54.81% in Mar 2024

Compare Profit and Loss Results of Fermenta Biotec.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
469.00
0
469.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
469.00
0
469.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-31.00
0
-31.00
0%
Raw Materials Consumed
178.00
0
178.00
0%
Power & Fuel Cost
27.00
0
27.00
0%
Employee Cost
65.00
0
65.00
0%
Operating Expenses
59.00
0
59.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
17.00
0
17.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
11.00
0
11.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
358.00
0
358.00
0%
Operating Profit (PBDIT) excl Other Income
110.00
0.00
110.00
0%
Other Income
11.00
0
11.00
0%
Operating Profit (PBDIT)
122.00
0
122.00
0%
Interest
14.00
0
14.00
0%
Profit before Depriciation and Tax
107.00
0
107.00
0%
Depreciation
24.00
0
24.00
0%
Profit Before Taxation & Exceptional Items
83.00
0
83.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
83.00
0
83.00
0%
Provision for Tax
6.00
0
6.00
0%
Profit After Tax
76.00
0
76.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
252.00
0
252.00
0%
Profit Available for appropriations
329.00
0
329.00
0%
Appropriations
329.00
0
329.00
0%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
26.35
0
26.35
0%
Profit And Loss - Net Sales
Net Sales 469.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 39.87% vs -4.08% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 110.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 296.21% vs 53.28% in Mar 2024

Profit And Loss - Interest
Interest 14.89 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.53% vs -18.47% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 76.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 418.23% vs 54.81% in Mar 2024